Another Subsidy For Business On the Way?

More so than Jay, I am troubled by Democratic Party proposals to fix our health care system that are built around the private insurance model. It is contradictory – it says that we fix the problem by spreading the problem around. The private insurance model is the reason why we have 47 million uninsured, millions more underinsured, and seniors, the poor, and children dumped onto government as the insurer of last resort.

Private insurance is a profit-driven model, and as such, has to confine itself to the lowest risk clients they can find. That’s the nature of the beast – it cannot be changed. Health insurance salespeople sift through the rubble looking for profitable clients, screening out the others. My wife and I, with our pre-existing conditions, have been told by agents not even to bother applying, and are sent packing instead to the ultra-expensive Montana health care pool for unprofitable health care clients. (It exists by government mandate – that alone is informative.)

So I am intrigued by Obama’s statements during the campaign, and by the Baucus proposal, that would make it illegal to reject people for insurance based on pre-existing conditions. I’m encouraged by this because it would undermine the private insurance model, and perhaps act as a driving force towards government-sponsored health care. No private insurer can survive if it has to provide insurance to all comers. Their business model is built around rejection of high risks.

Of course, the private insurance people are probalby miles ahead of me here. They might be willing to take on higher risk clients if we help them out – subsidy. That might well be our future – government-subsidized private insurance. That is the most expensive model we could possibly design, complete with all of the waste and extravagance of subsidy coupled with the greed and inefficiency and golden parachutes of the private insurers. It is no solution – it has all of the earmarks of a boondoggle.

The cleanest way to health care is to eliminate insurance pools, and simply provide care to everyone, high and low risk alike. Insurers can find other ways to make a living – an honest living. In other industrialized countries, it works just fine. People in Canada, Great Britain, France and Germany are mostly happy with their systems, far more satisfied than we are with ours. Maybe I’m being overly pessimistic here, but I see big brother private insurer in my future, want him or not. He’s bought his way in, and it will take major surgery to remove him.

Obama is a nice change, but he does not represent major change. That much is readily apparent as we watch him assemble his team with retreads, excluding progressives.

A Change of Tactics, But Not Stripes

Conservatives often change tactics, but never stripes. Their formula is simple, if not simplistic – Ronald Reagan said “The nine most terrifying words in the English language are: ‘I’m from the government and I’m here to help.'” Conservatives want to make government small and insignificant – so they say. They don’t see much in the way of practical use for it, and believe markets self-regulate and self-correct and that we are all best served by deregulated markets.

When evidence flies in their face, as with the current crisis, they usually find a way to blame government. And when it painfully apparent to most all of us that deregulation of the financial markets has created a massive financial squeeze – a near panic putting us on the brink of depression – conservatives go right along insisting that deregulation is a panacea in other areas too. Like, for instance, heath care.

Merrill Mathews, of the right wing think tank Institute for Policy Innovation as a marvelously innovative solution for our health care crisis: deregulation. But he’s not calling it that. He says it’s merely a different kind of regulation. In his op-ed in yesterday’s Wall Street Journal (McCain is Right on Interstate Health Insurance), Mathews offers up a long-standing right wing cure to health care woes: eliminate the barriers that prevent us from buying health insurance in states where we do not live.

Mr. McCain backs legislation sponsored by Arizona Rep. John Shadegg. Known as the Health Care Choice Act, it would allow individuals living in one state to purchase health insurance being sold to people living in other states. The policy would still have to meet the regulations of the state in which it is being sold, and would be subject to additional federal oversight.

In other words, the McCain-Shadegg reform would allow a person living in New Jersey or New York to buy health insurance that is being sold in and regulated by Pennsylvania or Connecticut. That’s hardly the Wild West of health insurance.

Various states around the union have looked at products offered by health insurers, and found them inadequate, often deceptive. So they have mandated coverages for things like maternity leave, mental illness, addictions, and many other items. The reasons are simple – for one, people gravitate towards the cheapest coverage when they are healthy, and usually under-insure themselves. In addition, many public health problems simply go untreated for lack of coverage. Health insurers want to minimize their financial risk, and so offer a range of coverages that tends to minimize their exposure.

Yes, it is more expensive to cover things than not to cover them, but there are valid public policy reasons for doing so. The insurance model is an inadequate vehicle for public health, so we have attempted to fix its deficiencies though law. Insurers don’t like it – they want to tailor coverages to maximize profits, and would rather not cover things that are highly likely to occur. That’s a guarantee of higher costs.

So addiction and mental illness go untreated, and maternity coverage is restricted to men over age 50. That’s the health insurance model.

Under Mathews plan, state regulations would go out the window, and we would automatically default to the policies of the state with the fewest regulations and cheapest insurance. All of Montana’s thoughtful legislation regarding health care policy would be set aside as our people go to Pennsylvania for their coverage. And insurers would flock to the state with the fewest regulations. Pennsylvania would become the new Delaware. We’d be right back where we started – too little coverage. That’s bad public policy.

Mathews surely knows this, but listen to him:

Mr. Obama opposes interstate sales … he doesn’t believe a market can work in health insurance. He believes it is necessary for the government to look over everybody’s shoulder to make sure patients are getting the care and coverage the government thinks is appropriate at a price the government considers affordable.

…Creating an interstate option for individuals to purchase health insurance doesn’t solve every problem faced by the 45 million Americans who are uninsured. But the choice isn’t between a regulated or unregulated health-insurance market. The choice is between an overregulated market favored by Mr. Obama and a regulated market favored by Mr. McCain that provides more options to help individuals afford health coverage.

So Mr. McCain actually favors a regulated market, and would give it to us by doing de facto deregulation.

I love conservatives – they never change – they don’t adapt. Perhaps they are doomed to extinction.

Superbugs and the Free Market

We are faced with a serious problem, one requiring the full faith and credit of the free market. We need to unleash resources and creativity. That’s what markets do best, right?

The problem is drug-resistant bacteria and diseases that cannot be cured with existing strains of antibiotics. Yet market incentives are perverse. The marketplace is just as often our enemy as our friend.

This is from an article by Jerome Groopman in the New Yorker, Superbugs, August 11/18 issue:

In the past, large pharmaceutical companies were the primary sources of antibiotic research. But many of these companies have abandoned the field. “Eli Lilly and Company developed the first cephalosporins,” Moellering told me, referring to familiar drugs like Keflex. “They developed a huge number of important anti-microbial agents. They had incredible chemistry and incredible research facilities, and, unfortunately, they have completely pulled out of it now. After Squibb merged with Bristol-Myers, they closed their antibacterial program,” he said, as did Abbott, which developed key agents in the past treatment of gram-negative bacteria. A recent assessment of progress in the field, from U.C.L.A., concluded, “FDA approval of new antibacterial agents decreased by 56 per cent over the past 20 years (1998-2002 vs. 1983-1987),” noting that, in the researchers’ projection of future development only six of the five hundred and six drugs currently being developed were new antibacterial agents. Drug companies are looking for blockbuster therapies that must be taken daily for decades, drugs like Lipitor, for high cholesterol, or Zyprexa, for psychiatric disorders, used by millions of people and generating many billions of dollars each year. Antibiotics are used to treat infections, and are therefore prescribed only for days or weeks. (The exception is the use of antibiotics in livestock, which is both a profit-driver and a potential cause of antibiotic resistance.)

If there is a solution to this problem, it will come from the college campuses and the National Institute of Health – government sources. The market is not helping – in fact – is structurally unable to help. This phenomenon is known as “market failure” – the public is disserved by the profit motive. In such situations, government has to intervene to provide for the greater good.

It’s interesting – I realized as I wrote those words that in the past in my exchanges with Dave Budge (a libertarian conservative Republican who at any given time denies affiliation to any of those three schools), he claimed not to grasp the concepts of “market failure” and “greater good”. Ayn Rand herself did not believe in individuals sacrificing to a greater good – that is, she did not think there was any point in people serving anything but their own self-interest. Perhaps libertarianism, a sideshow that has much greater currency in leadership circles than among the general population, is a failed philosophy.

Superbugs are a common problem affecting all of us. Those institutions that profit from the public’s need for drugs have an obligation to step in and help us solve the problem. But they’re not – they’re busy doing the self-interest thing. Rand would be proud.

Rabid Sanity Tackles Health Care

In an exchange I had with Steve at Rabid Sanity regarding health care, he referred me to two articles that take issue with the current low ranking by World Health Organization of the United States’ health care system against other industrialized countries. We’re 37th. The two articles dispute the rankings, saying they are biased in favor or state-run systems. Our system is not “perfect” one admits, but is probably the best in the world.

The first article is How surveys twist rankings on health care, by Glen Whitman. The problem is, he says, the objectives of the study.

The most obvious bias is that 62.5 percent of their weighting concerns not quality of service but equality. In other words, the rankings are less concerned with the ability of a health system to make sick people better than with the political consideration of achieving equal access and state-controlled funding.

This, he says, is a flaw in the study. The United States is very good at making sick people better – not all sick people, but that’s not the point. A health care system should be measured by its abilities, and not its delivery capacity. That 47 million of us are without insurance? Not an issue. Bias.

The rankings include measures for “health level” and “responsiveness.” “Health level” is their way of saying life expectancy, while “responsiveness” refers to a survey based on “respect for persons” and elements such as speed of service, convenience and choice — yet even in these cases half the overall weighting is determined by considerations of equality. Thus, a country with a poor level of “responsiveness” throughout the population will score higher than a country with a good level in some parts and an excellent level in others.

It’s in the eye of the beholder, I guess. Whitman is a professor of economics, and is not concerned about equality. And he is right: If you only measure the people we actually take care of in this country, we’re the toast of the town.

The second article, Ranking the U.S. Health-Care System, by Jim Peron (for whom it gives no credentials), says pretty much the same thing, but from a doctrinal standpoint. Peron starts off by using the word “socialist” as a pejorative, so it’s not hard to see where he’s going. Referring to a study by the Commonwealth Fund that also ranked the U.S. very low, he says

The Commonwealth Fund marked down the United States partly because “All other major industrialized nations provide universal health coverage, and most of them have comprehensive benefits packages with no cost-sharing by the patients.” Again the American system loses points because it doesn’t provide socialized medicine. And the Times neglected to note that “no cost-sharing” means the people have paid through taxes whether they receive the care or not.

This is a curiosity. The concept of insurance is based on shared risk, no different than coverage of people’s health care through taxation, also a shared-risk system. But Peron presumes that private insurance is a superior model because it is not based on taxation. That’s nothing more than personal bias.

This is priceless:

This issue is not unknown to the Commonwealth Fund. In 1999 it
published The Elderly’s Experiences with Health Care in Five Nations, which found significant delays for “serious surgery.” Only 4 percent of the American seniors reported long waits for serious surgery. The rate was 11 percent in Canada and 13 percent in Britain. For non-serious surgery the differences were more obvious: 7 percent in the United States, 40 percent in Canada, and 51 percent in Britain.

He’s talking about seniors. He doesn’t seem to realize it, but he’s comparing our Medicare, or government-sponsored system that is supported by taxes, with other countries. I’m happy that Medicare is doing well in that regard. It’s a well-run system.

In other areas, Peron simply offers up weak, made-up-on-the-spot excuses.

The United States also lost credit because fewer Americans report having a regular doctor for five years or more. But Americans are more mobile than many other people.CNN reports that Americans move every five years on average.

He does that in other areas as well, as in emergent care wait periods, lack of centralized medical records, and the number of patient complaints. (“But different cultures have different attitudes toward complaining.”)

It’s all illuminating, but not of the relative merits of health care systems. In terms of equality and delivery of care, the U.S. lags far behind other countries. But these articles, and Steve’s post to begin with, shine a light not on study biases, but rather on right wing biases. Yes, we don’t offer care to everyone. We don’t intend to! Yes, our care for the wealthy and well-insured is excellent. Those are the people the system is meant to serve.

The system works as it is intended to work, delivering excellent care to insiders, and poor or no care to outsiders. When we debate conservatives like Steve on this issue, that is the subtext, and the issue we need to highlight. Conservatives are far too caught up in rewarding the financially well-off. In health care, that’s a poor objective. Even if they attain it, they have failed us.

For that reason, they need to step aside and let us “socialists” fix our health care system. It’s long overdue. We have real answers while they offer nothing other than a curtsy to Ayn Rand.

An American Story

A Livingston, Montana man, Terry, once worked for a small sign company, but the wages were bad, the hours irregular. Still, the company at one time provided health insurance benefits, so the job had its value. But citing rising costs, the company dropped that benefit. Terry was left working for low wages ($12 per hour) and no benefits. He realized he could make more money on his own, but that he would lose the two protections left employed people that are mandated by state law: Workers Compensation insurance, and unemployment benefits.

Terry struck out on his own, and has been hiring himself out for any sort of craftsman’s work in the Livingston area. He bills at a much higher rate than he was paid in wages, and makes enough money to pay his bills. However, health insurance is still out of the question as he and his wife are in their fifties, and premium costs are out of reach. And who knows – at that age, they might have preexisting conditions. They had to go bare – it’s a chance they had to take.

This week Terry had an accident on a job, and broke both of his shoulder blades. He is now laid up, deep in medical debt and has no income to boot.

Soon to come: bankruptcy and tut-tuts that he should have managed his money better.

Weekend Reading

I’ve been trying of late to get a grip on the huge American pharmaceutical business, without much success. It’s very big and the machinations and maneuverings and political intrigue involved in bringing a drug to market overwhelm me. But here is what I have gleaned so far:

  • The FDA is largely compromised these days, and has given into pharmaceutical demands for streamlined drug approval at the expense of safety and efficacy.
  • Drug testing is largely done under the control of the companies that produce the drugs. They are held to low standards, having only to show that new drugs are better than a placebo, and are not tested against existing drugs that are often cheaper and more effective.
  • The heart of big pharma is the TV ads they run, which they use to push their worst products – the ones that do little and cost much. Only the United States and New Zealand allow such advertising, and doctors, who are marketed to separately on the other end, are very susceptible to it.
  • Much of what passes for new drugs on the market are actually “me too” drugs that imitate other drugs. Other drugs that come to market are actually given to us in response to conditions created by the drug manufacturers to create a market for their product. (“Acid reflux syndrome” (heartburn) is one.) Drug manufacturers are not very interested in finding remedies for non-chronic conditions or for things that afflict only a few hundred thousand people (for which they have to be subsidized.) Widespread and deadly diseases, like malaria, are low priority because the people that get these diseases are poor and cannot afford expensive treatments.
  • Much of what is patented or licensed for exclusive marketing are merely cosmetic changes in dosage or color and shape of existing drugs to extend their patents. Pharmaceuticals spend billions of dollars in court cases to keep generic drugs off the market and even more in research to make non-substantive changes to medications.
  • Drug companies spend far more money marketing their products than they do on research and development. Most research is done by the National Institute of Health (NIH) and on campuses and universities. Breakthroughs usually come from that source and small startups, and are then bought up by the big pharmaceutical companies, who pay small royalties in return for the right to market these products. There’s very little new coming down the pipeline, and precious little of that from the big companies. That’s not what they are about.
  • Drug companies are the most powerful lobby in Washington, and can virtually write their own ticket, as they did with Medicare D, in which legislators like our Senator Max Baucus were convinced that Medicare should not be able to bargain with drug companies to lower prices. Baucus still stands by that ludicrous proposition.
  • So powerful is the pharmaceutical lobby that the simplest of laws, such as allowing reimportation of cheaper drugs from abroad to lower prices here, cannot be passed.
  • The following link is to an interview done by Jake Whitney of Guernica Magazine with Dr. Peter Rost, a whistleblower who once worked for Pfizer and has since attempted to make his career as author and expert witness. He runs a website that focuses on pharmaceutical issues, but also has a wide variety of interesting subjects.

    Here are a few quotes from the interview:

    Guernica: You’ve described the pharmaceutical industry as mob-like. What did you mean by that?

    Peter Rost: It is scary how many similarities there are between this industry and the mob. The mob makes obscene amounts of money, as does this industry. The side effects of organized crime are killings and deaths, and the side effects are the same in this industry. The mob bribes politicians and others, and so does the drug industry—which has been proven in different cases. You could go though a 10-point list discussing similarities between the two. The difference is, all these people in the drug industry look upon themselves—well, I’d say 99 percent, anyway—look upon themselves as law-abiding citizens, not as citizens who would ever rob a bank. Not as citizens who would ever go out and shoplift. And the individuals who run these companies would probably not do such things. However, when they get together as a group and manage these corporations, something seems to happen. Just look at all of these billion-dollar fines—Schering Plough, I think is in the lead now with $1.2 or $1.3 billion in fines; and number two is Bristol-Myers Squibb. It’s pretty scary that they’re committing crimes that cause [the government] to levy those enormous amounts of fines against them. So there’s something that happens to otherwise good citizens when they are part of a corporation. It’s almost like when you have war atrocities; people do things they don’t think they’re capable of. When you’re in a group, people can do things they otherwise wouldn’t, because the group can validate what you’re doing as okay.

    Guernica: You said one similarity between the drug industry and the mob was that in both the side effects are “killings and deaths.” As that pertains to the drug industry, I’m assuming you mean in unintentional deaths resulting from unforeseen side effects—unlike the mob, which intentionally kills people.

    Peter Rost: Clearly, the drug industry doesn’t want to kill people. But at the same time, I’m not sure if it’s always completely unintentional. Yeah, they don’t want to kill people because it’s bad for business, right. But if you look at a number of these cases where people inside the company knew they had problems. If you look at Merck with Vioxx, for example; if you look at Bayer and the lipid-lowering drug they had that caused liver failure, Baycol. Those guys knew that these drugs were causing major problems. And they knew these problems resulted in serious side effects, including death. Yet they kept on selling the drugs. So is that intentional or not?

    Guernica: In your 2007 book, Killer Drug, you have a character named Torrance who’s the head of security at a fictional drug company called Xenal. Torrance is an extremely shady character who won’t hesitate to murder enemies of the company. The book is a novel, of course, but did you come across anyone in your career who gave you the feeling that he could possibly act like Torrance?

    Peter Rost: The book is fiction. But it is using some of what I’ve seen and experienced, and taking some of the different people and putting them in a thriller environment. I’m not aware of individuals conducting themselves the way Torrance does. At the same time, I am aware that the kind of background he has is very common in the drug industry for someone who is heading up security. Pfizer has a former FBI agent, John Theriault, heading up its security department. And he has lots of law enforcement officers working under him. We have to recognize that these big companies are all building small paramilitary organizations inside the companies that answer to no one except the company itself. Look at Hewlett Packard, how they abused security consultants by getting phone records and information about journalists… and you know we only know a tiny fraction about what really happens—we only find out when these companies happen to get caught. It shows that there aren’t really any limits to what big companies—in the drug industry and others—will do.

    It’s an interesting interview if you have time and interest. Discouraging for me was Rost’s statement that he doesn’t think there will be any significant change in the U.S. health care system for thirty or fifty years, since so many people from doctors to pharmas to lawyers to insurance companies are making gadzillions of dollars on it. Do you think that a Democratic Administration will change things? Think again. As Rost notes, Pfizer’s new CEO Jeff Kindler and the incoming stream of executive appointments are all Democrats. As Dr. Alan Grant said of the velociraptors and Captain Jean-luc Pecard of the Borg, “they’re adapting”.

    Says It All

    I’m going to do a left equivalent of a RWCJ* thing here, and link to another left wing blog and repeat what was said over there in hopes that others will do the same, in time producing a cacophony of voices each saying the same thing, thereby lending authority and importance to the insignificant.

    But I came upon a sentence in a post about health care at Left in the West, and thought that it did so well what I do so poorly – saying a lot while saying a little.

    Missoula doctor Tom Roberts: “Our profit-based system is fundamentally at odds with our valued-based system.”

    *Right Wing Circle Jerk

    Interview with a Canadian

    The following is an interview I found interesting, between radio talk-show host Thom Hartmann and Dr. Lewis Mehl-Madrona, the author of Coyote Healing, Miracles in Native Medicine, and a number of other books. He’s a PhD and MD, Professor of Medicine at the University of Saskatchewan College of Medicine, and out on the East Coast practices at Beth Israel Medical Center. He’s also a practicing psychiatrist in Canada.

    One thing I’ve noticed over the years is that, when we talk of Canadian medicine here in the United States, we don’t talk to Canadians (unless they are unhappy with that system). So we don’t get personal testimony about what single-payer means to ordinary Canucks. The following interview is limited, but does give some insight.

    TH: You have practiced and taught medicine in the United States for the better part of a couple of decades …

    LM: It’s been 32 years since I got my MD.

    TH: …and you are now teaching and practicing medicine in Canada. Last night 60 Minutes did this amazing piece on a charity called Remote Area Medical that typically goes into third world countries or worse and sets up two and three day emergency medicine clinics for people who have never seen a doctor or are not going to have opportunity to see a doctor, and diagnostic and treatment facilities. And they did this in Knoxville, Tennessee, and people drove from hundreds of miles around and sat freezing in line all night long – they were absolutely overwhelmed. The state of American medical care for anyone who makes less than (fill in the blank) – somewhere between $40 and $70 thousand bucks a year, is not unlike that in a third world country. Or worse. And that’s not the case in Canada. Can you quickly describe for us what it is like in Canada? You teach there, you practice there, you are presumably a consumer of medical services in Canada. What is it like, and what would it take for the United States to make the transition into a Canadian-style system?

    LM: Probably the simplest thing is that nobody worries about how we’re going to pay for anything, so as a patient you just go to the doctor and you don’t really worry about how much it costs. You just hand them your card and they bill for it and that’s that. And as a doctor, we’re not really worried about how you’re going to pay for it either. We just do what we think is best and that’s that. What’s amazing going to Canada from the U.S. is that no one ever asks what kind of insurance you have. No one ever questions whether or not you can pay for something. People get what they need. Yes, sometimes they wait for elective surgery, basically because there aren’t enough operating rooms, or sometimes it’s because there are not enough surgeons. But if it’s an emergency, it’s quick. There’s no such thing as what’s called utilization review. When I practiced in the U.S., someone from the U.R. department would come see me every day to try and kick people out of the hospital because they were costing money, or if I wanted to admit somebody to the hospital they would refuse.

    TH: You see these shows like House, here in the United States, which is supposed to take place in Princeton Medical Center, and he says “Order an MRI and do a test for this”, and in reality, it would be “Would you please find if the insurance company will pay for an MRI?” It’s such a twisted view of medicine. What we’re seeing in our TV shows is medicine s it’s practiced in Canada or as it’s practiced in Europe, but they’re taking place in the United States. It’s bizarre.

    LM: It is. You know, Canada has its problems – we still order too many lab tests, we spend less time with people that we should – it’s less severe than the United States, because in Canada as a family physician you can bill for every fifteen minutes that you spend with a patient, whereas here, as a family physician, you’re “tapped”, and so you can only bill for the first six minutes.

    TH: After that the insurance companies won’t pay for it. That’s why the doctors try to get you out of the office as fast as they can, because after six minutes they’re not being paid anymore.

    LM: So now, in Canada, if you see people very six minutes you can still make more money than if you see them every fifteen minutes. So, for instance, as a family physician, you would make about forty dollars for a fifteen minute office visit, but if you can do that in six minutes you still make forty dollars. Here you probably make about, I’m guessing, thirty dollars for an office visit, and so if you see them every six minutes you’re still making enough money to pay your overhead. But you can, in Canada, choose to see people every fifteen minutes, or you can see the same person for an hour …

    TH And bill for four fifteen minute segments.

    LM: That’s right.

    TH: So then I can hear conservatives all over America screaming “Oh my God, people who just love to go to the doctor’s office are just going to come in and talk your ear off and I’m going to have to pay for it. It must cost a fortune!”

    LM: Let me tell you about that. I’m using an American example, I have a friend in Scottsdale who has what’s called a “concierge’s practice”, and she’s a family physician, and she limits her practice to 250 people, and each of those people pay her $2,000 at the start of each year. They can come see her as much as they want. They can see her as long as they want. They never have to pay another penny. And what she found was that people see her a lot less than she wants them to when they can come as much as they want. And people get tired and they leave before she’s ready to stop the appointment.

    TH: So the reality is that this whole myth of the people who want to take advantage of the system because it’s free is nonsense. There may be some small, one-thousandth of one percent of the people – the ones who are compulsive about having surgeries – there is a medical condition there you probably know the name of and I don’t. That’s the exception.

    LM: Right. It’s really not a lot of fun to go to the doctor. … And every study that’s been done has shown that if you give people the time they need when they need it, they actually consume less resources over the course of a year. It costs you less to take care of people.

    TH: Both because of preventive care and because people generally have better things to do than hang out at the doctor’s office.

    LM: Right.

    TH: And if the United States was to make this transition to a Canadian-style system, or more European style, a single-payer system, what is it that we would have to change, structurally or psychologically here in the United States in order for that to happen?

    LM: People would have to change the idea that they deserve every test immediately, right now. A quick example, I know someone in Anchorage, Alaska, a 54 year old woman who smokes a couple cigarettes a day and doesn’t exercise, has high stress, had chest pain and went to the ER. The logical thing to do would be to make sure she’s not having a heart attack and schedule her for a stress test or a treadmill test where she walks on the treadmill …

    TH: To make sure she’s not having a panic attack …

    LM: Right. So what happened is she went straight to cardiac cath, a test that costs at least $20,000 …

    TH: A cardiac cath is where they put the long tube in the femoral artery and snake it up into the heart and do this all under X rays. And this has a certain rate of death associated with it – nine out of a thousand?

    LM: Not death, but some kind of stroke kills nine percent in one study [I think he meant to say that strokes are experienced by 9/10 of one percent of those who are subjected to this procedure.] So here’s a risky procedure that could have caused her many problems that cost $20,000, that really wasn’t necessary, and after she was done she was so grateful to them because they definitively proved that there was nothing wrong with her.

    TH: Where instead of a $20,000 very dangerous procedure, they could have done a thirty dollar test – a blood test that would have shown that …

    LM: Well, a treadmill test would probably be more like an $800 test, but if you pass your treadmill test, your chances of having a heart attack in the year are minimal.

    Hillarycare Redux

    Hillary Clinton has taken more money from the heath care industry, including the pharmaceuticals, than any other politician in Washington, Republicans and Democrats alike. We’re in rah-rah mode right now, and so not scrutinizing candidates from a contribution standpoint. Nor will we.

    Democrats don’t think it means anything, her taking all this money from that sector. That’s a kind of willfully blind mentality that goes hand in paw with being a Democrat.

    Think back to Hillarycare back in the early 90’s. She proposed that we turn our health care system over to the largest corporations in that field – Aetna, Travelers, and others. But the plan was blown out of the water when smaller health care companies that had been shut out banded together and put together a clever ad campaign, featuring Harry and Louise. It ran in key congressional districts, and pretty well Swiftboated the plan. Just as well.

    Hillary and Bill never touched the health care issue again. Never went close to it. That’s their legacy – first they attempted to corporatize the system in total. After that, nothing.

    Here’s what I think Hillary’s support from the industry means: They want to be dealt into her plan. Change is inevitable. While progressives have long supported single payer, Hillary will steal the baton and lead us down the road to a top-heavy, overly expensive and heavily subsidized corporate health care system.

    That’s what those contributions mean. Contrary to what Hillary tells us, contrary to what Democrats think, that money is speaking to her, and she is listening.